EMA Recommends EU Conditional Approval of Roche’s Mosunetuzumab April 25, 2022 Auto Bot News 0 EMA is recommending EU conditional approval of Roche’s potential first-in-class bispecific antibody mosunetuzumab for people with relapsed or refractory follicular lymphoma.